New therapeutic strategy for cancer targeting the hedgehog signaling pathway

Masafumi Nakamura, Makoto Kubo, Shuntaro Nagai, Koji Yamaguchi, Masao Tanaka, Mitsuo Katano

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The hedgehog (Hh) signaling pathway was originally found as an organizer in embryonic development. The pathway is now implicated in the development of various tumors. Recently, it has been reported that the pathway activation is resulted from aberrant expression of the ligand, Sonic Hh (Shh), in pancreatic cancer and breast cancer. Here we developed a new strategy to control the activation of the Hh signaling pathway in cancer cells, which have ectopic and ligand dependent activation of the Hh signaling pathway. Our strategy may contribute to the development of a new cancer treatment.

Original languageEnglish
Pages (from-to)1914-1916
Number of pages3
JournalGan to kagaku ryoho. Cancer & chemotherapy
Volume34
Issue number12
Publication statusPublished - Jan 1 2007

Fingerprint

Breast Neoplasms
Ligands
Neoplasms
Pancreatic Neoplasms
Embryonic Development
Therapeutics

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

New therapeutic strategy for cancer targeting the hedgehog signaling pathway. / Nakamura, Masafumi; Kubo, Makoto; Nagai, Shuntaro; Yamaguchi, Koji; Tanaka, Masao; Katano, Mitsuo.

In: Gan to kagaku ryoho. Cancer & chemotherapy, Vol. 34, No. 12, 01.01.2007, p. 1914-1916.

Research output: Contribution to journalArticle

@article{06770ba50ed04be791271d2ba5233320,
title = "New therapeutic strategy for cancer targeting the hedgehog signaling pathway",
abstract = "The hedgehog (Hh) signaling pathway was originally found as an organizer in embryonic development. The pathway is now implicated in the development of various tumors. Recently, it has been reported that the pathway activation is resulted from aberrant expression of the ligand, Sonic Hh (Shh), in pancreatic cancer and breast cancer. Here we developed a new strategy to control the activation of the Hh signaling pathway in cancer cells, which have ectopic and ligand dependent activation of the Hh signaling pathway. Our strategy may contribute to the development of a new cancer treatment.",
author = "Masafumi Nakamura and Makoto Kubo and Shuntaro Nagai and Koji Yamaguchi and Masao Tanaka and Mitsuo Katano",
year = "2007",
month = "1",
day = "1",
language = "English",
volume = "34",
pages = "1914--1916",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "12",

}

TY - JOUR

T1 - New therapeutic strategy for cancer targeting the hedgehog signaling pathway

AU - Nakamura, Masafumi

AU - Kubo, Makoto

AU - Nagai, Shuntaro

AU - Yamaguchi, Koji

AU - Tanaka, Masao

AU - Katano, Mitsuo

PY - 2007/1/1

Y1 - 2007/1/1

N2 - The hedgehog (Hh) signaling pathway was originally found as an organizer in embryonic development. The pathway is now implicated in the development of various tumors. Recently, it has been reported that the pathway activation is resulted from aberrant expression of the ligand, Sonic Hh (Shh), in pancreatic cancer and breast cancer. Here we developed a new strategy to control the activation of the Hh signaling pathway in cancer cells, which have ectopic and ligand dependent activation of the Hh signaling pathway. Our strategy may contribute to the development of a new cancer treatment.

AB - The hedgehog (Hh) signaling pathway was originally found as an organizer in embryonic development. The pathway is now implicated in the development of various tumors. Recently, it has been reported that the pathway activation is resulted from aberrant expression of the ligand, Sonic Hh (Shh), in pancreatic cancer and breast cancer. Here we developed a new strategy to control the activation of the Hh signaling pathway in cancer cells, which have ectopic and ligand dependent activation of the Hh signaling pathway. Our strategy may contribute to the development of a new cancer treatment.

UR - http://www.scopus.com/inward/record.url?scp=39049161586&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39049161586&partnerID=8YFLogxK

M3 - Article

VL - 34

SP - 1914

EP - 1916

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 12

ER -